Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance - Andrew F. Shorr; Mark E. Jones; Silke Friedmann; Daniel Ionescu; Mikael Saulay; Jennifer I. Smart; Marc Engelhardt (PLoS ONE, 2025)